Search

everythinglearnresearchcommunity

for

Search:↓

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Umbilical cord cells safely improve healing in long-term nonhealing wounds better than a placebo.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Use 5% minoxidil or oral finasteride for mild-to-moderate hair loss, combine with hair transplant for severe cases.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Various treatments exist for hair loss, but more research is needed for better options.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Periodontal ligament stem cells show promise for regrowing tissues but require more research for safe, effective use.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Thread monofilament and minoxidil together increase hair growth in female androgenetic alopecia.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Fractional resurfacing is safe and effective for certain skin conditions in Asian patients, but care must be taken to avoid skin pigmentation issues.

Laser and minoxidil combo promotes better hair growth than minoxidil alone, safely.

No genetic link between prostaglandins and hair loss found.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.